01
20 Billion Exosome Particles / 5 mL
Standardized content with high particle density.
EFBA EXONOVA7
Standardized Wharton's Jelly-Derived Exosome Solution
Scientific standardization. Traceable quality. Reliable manufacturing.
Exosome
EXONOVA7 is a premium exosome solution derived from Wharton's Jelly mesenchymal stem cells, standardized through validated manufacturing processes and delivered under cold-chain assurance.
Every vial passes through quality control from production to shipment, prepared with the goal of batch-to-batch consistency.
Standardized Content
02
Wharton's Jelly Derived
Produced from Wharton's Jelly-derived mesenchymal stem cells, ethically obtained after birth.
03
98% Stem Cell Antigen
High-purity, cell-derived content.
04
286 mg Protein Structure
Standardized content supporting the exosomal protein profile.
EFBA EXONOVA7 is manufactured at Vivosel Laboratories, built on rigorous quality standards.
- cGMP-compliant manufacturing processes
- ISO-compliant quality system
- Sterile filling and sterile vials
- Endotoxin-tested product
- Validated manufacturing processes
- Batch-based quality control
- Traceable production records
Certificates of Analysis (CoA), batch test results, and quality control reports can be shared for the products upon request.
Request a Quote for EFBA EXONOVA7
Submit your quote request for certificates of analysis, supply terms, and pricing — our team will get in touch.